Pay in 4 interest-free payments of $7.11 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
Table of Contents Understanding Mounjaro and Its Gastrointestinal Effects Mounjaro (tirzepatide) is a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist licensed in the UK for the treatment of type 2 diabetes mellitus and, more recently, for weight management in adults with obesity (BMI 30 kg/m) or overweight (BMI 27 kg/m) with weight-related comorbidities
Its ~5day halflife allows convenient onceweekly subcutaneous dosing [1]
Dietary Modifications Since the liver is already working overtime to process TMA, reducing other dietary sources of TMA can help lighten the load [6]
doi: 10.1080/19390211.2021.1874587 55
Connect with our team for project support: References: Khavinson VKh
US$ 29.75
US$ 25.78
US$ 27.69
US$ 23.21
